Skip header and navigation
The BC Cancer Library

Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.

  Refine by:

Refine by:

Format

2 records – page 1 of 1.

Combined estrogen-progestogen contraceptives|and combined estrogen-progestogen menopausal therapy

https://bccalibrary.andornot.com/en/permalink/catalog16349
International Agency for Research on Cancer, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2005 June 7-14 : Lyon, France), World Health Organization. Lyon, France: International Agency for Research on Cancer , 2007.
Audience
Professional
Call Number
QZ202 I585 2007 v.91
Availability
1 copy, 1 available
More Information
  2 read online  
Corporate Author
International Agency for Research on Cancer
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2005 June 7-14 : Lyon, France)
World Health Organization
Place of Publication
Lyon, France
Publisher
International Agency for Research on Cancer
Publication Date
2007
Physical Description
ix, 528 p. : ill. ; 24 cm.
Series
IARC monographs on the evaluation of carcinogenic risks to humans 91
Subjects
Contraceptives, Oral, Hormonal - adverse effects
Estrogens - therapeutic use
Hormone Replacement Therapy - adverse effects
Neoplasms - chemically induced
Neoplasms - prevention & control
Progestins - adverse effects
Progestins - therapeutic use
ISBN
9789283212911
ISSN
1017-1606
Language
English
Material Type
Book
Online
Audience
Professional
Location
Vancouver Library
Internet
Call Number
QZ202 I585 2007 v.91
Read Online
http://monographs.iarc.fr/ENG/recentpub/mono91.pdf
http://monographs.iarc.fr/ENG/Monographs/vol91/index.php

Copies

c.1 BC Cancer Agency VAN Library Available
Show Less

RANK ligand : a key signal in cancer-induced bone disease and hormone ablative therapy-induced bone loss

https://bccalibrary.andornot.com/en/permalink/catalog19811
Amgen Inc. Thousand Oaks, Calif.: Amgen Inc. , 2009.
Audience
Professional
Call Number
WE258 R198 2009
Availability
1 copy, 1 available
Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss
More Information
Author
Amgen Inc.
Place of Publication
Thousand Oaks, Calif.
Publisher
Amgen Inc.
Publication Date
2009
Subjects
RANK Ligand - metabolism
Osteoblasts
Osteoclasts
Antibodies, Monoclonal - therapeutic use
Bone Neoplasms - secondary
Bone Resorption
Osteoporosis - therapy
Antineoplastic Agents, Hormonal - adverse effects
Abstract
Introduction
RANK ligand in bone biology
Bone metastases
Multiple myeloma
Skeletal-related events (SREs)
Hormone ablative therapy-induced bone loss
Language
English
Material Type
Video
DVD
Audience
Professional
Location
Abbotsford Library
Call Number
WE258 R198 2009

Copies

c.1 BC Cancer Agency ARHCC Library Available
Show Less